Amdocs [DOX] vs Oracle [ORCL] Detailed Stock Comparison

Amdocs

NASDAQ
Loading...

Oracle

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Amdocs wins in 11 metrics, Oracle wins in 8 metrics, with 0 ties. Amdocs appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricAmdocsOracleBetter
P/E Ratio (TTM)16.6666.08Amdocs
Price-to-Book Ratio2.5833.66Amdocs
Debt-to-Equity Ratio23.65452.53Amdocs
PEG Ratio1.20-35.02Oracle
EV/EBITDA9.6637.37Amdocs
Profit Margin (TTM)11.94%21.08%Oracle
Operating Margin (TTM)17.69%31.38%Oracle
EBITDA Margin (TTM)17.69%31.38%Oracle
Return on Equity15.73%69.24%Oracle
Return on Assets (TTM)7.87%7.15%Amdocs
Free Cash Flow (TTM)$618.93M$-394.00MAmdocs
Dividend YieldN/A0.81%N/A
1-Year Return-6.66%67.47%Oracle
Price-to-Sales Ratio (TTM)1.9513.82Amdocs
Enterprise Value$9.59B$914.26BOracle
EV/Revenue Ratio2.0615.49Amdocs
Gross Profit Margin (TTM)37.86%67.28%Oracle
Revenue per Share (TTM)$41$21Amdocs
Earnings per Share (Diluted)$4.94$4.33Amdocs
Beta (Stock Volatility)0.521.53Amdocs
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Amdocs vs Oracle Stock Performance Analysis

Loading Price Chart...

Amdocs
Oracle
Amdocs Stock Overview | Oracle Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Amdocs0.13%0.85%-2.72%-11.10%-6.80%-2.19%
Oracle1.90%0.95%28.06%20.57%108.51%72.34%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Amdocs-6.66%1.29%38.59%40.84%185.24%209.36%
Oracle67.47%352.11%367.93%651.02%921.93%2,288.48%

News Based Sentiment: Amdocs vs Oracle

Amdocs

News based Sentiment: MIXED

Amdocs delivered a mixed bag in October, with a slight earnings beat and continued AI investment offset by declining revenue. The positive analyst ratings and institutional activity suggest confidence, but the revenue trend warrants close monitoring. Overall, the month presents a cautiously optimistic outlook.

View Amdocs News Sentiment Analysis

Oracle

News based Sentiment: MIXED

October was a pivotal month for Oracle, marked by a massive surge in RPO driven by the OpenAI partnership, but also overshadowed by concerns about rising debt, high valuation, and insider selling. The mixed analyst reactions and regulatory scrutiny add to the complexity, making it a significant month for investors to reassess the risk-reward profile.

View Oracle News Sentiment Analysis

Performance & Financial Health Analysis: Amdocs vs Oracle

MetricDOXORCL
Market Information
Market Cap i$9.09B$819.55B
Market Cap CategoryMid capMega cap
10 Day Avg. Volume i959,58028,166,510
90 Day Avg. Volume i866,19329,452,477
Last Close$82.43$291.59
52 Week Range$78.61 - $95.41$118.86 - $345.72
% from 52W High-13.60%-15.66%
All-Time High$99.75 (Jun 26, 2023)$345.72 (Sep 10, 2025)
% from All-Time High-17.36%-15.66%
Growth Metrics
Quarterly Revenue Growth-0.08%0.12%
Quarterly Earnings Growth0.10%0.00%
Financial Health
Profit Margin (TTM) i0.12%0.21%
Operating Margin (TTM) i0.18%0.31%
Return on Equity (TTM) i0.16%0.69%
Debt to Equity (MRQ) i23.65452.53
Cash & Liquidity
Book Value per Share (MRQ)$31.85$8.50
Cash per Share (MRQ)$3.11$3.87
Operating Cash Flow (TTM) i$737.18M$21.53B
Levered Free Cash Flow (TTM) i$563.54M$-2,832,250,112
Dividends
Last 12-Month Dividend Yield iN/A0.81%
Last 12-Month Dividend iN/A$1.70

Valuation & Enterprise Metrics Analysis: Amdocs vs Oracle

MetricDOXORCL
Price Ratios
P/E Ratio (TTM) i16.6666.08
Forward P/E i11.7139.96
PEG Ratio i1.20-35.02
Price to Sales (TTM) i1.9513.82
Price to Book (MRQ) i2.5833.66
Market Capitalization
Market Capitalization i$9.09B$819.55B
Enterprise Value i$9.59B$914.26B
Enterprise Value Metrics
Enterprise to Revenue i2.0615.49
Enterprise to EBITDA i9.6637.37
Risk & Other Metrics
Beta i0.521.53
Book Value per Share (MRQ) i$31.85$8.50

Financial Statements Comparison: Amdocs vs Oracle

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)DOXORCL
Revenue/Sales i$1.14B$15.90B
Cost of Goods Sold i$711.15M$4.74B
Gross Profit i$433.29M$11.16B
Research & Development i$86.85M$2.65B
Operating Income (EBIT) i$202.47M$5.19B
EBITDA i$252.11M$7.00B
Pre-Tax Income i$190.77M$4.15B
Income Tax i$35.96M$725.00M
Net Income (Profit) i$154.80M$3.43B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)DOXORCL
Cash & Equivalents i$247.39M$10.79B
Total Current Assets i$1.56B$24.58B
Total Current Liabilities i$1.34B$32.64B
Long-Term Debt i$748.93M$96.83B
Total Shareholders Equity i$3.50B$20.97B
Retained Earnings iN/A$-15.48B
Property, Plant & Equipment i$874.85M$0

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)DOXORCL
Operating Cash Flow i$195.07M$5.93B
Capital Expenditures i$-15.96MN/A
Free Cash Flow i$156.49M$-2.92B
Debt Repayment iN/A$-6.07B
Common Stock Repurchase i$-135.24M$-150.00M

Short Interest & Institutional Ownership Analysis

MetricDOXORCL
Shares Short i4.41M23.58M
Short Ratio i5.210.97
Short % of Float i0.05%0.01%
Average Daily Volume (10 Day) i959,58028,166,510
Average Daily Volume (90 Day) i866,19329,452,477
Shares Outstanding i112.89M2.81B
Float Shares i107.73M1.67B
% Held by Insiders i0.00%0.41%
% Held by Institutions i0.99%0.45%

Dividend Analysis & Yield Comparison: Amdocs vs Oracle

MetricDOXORCL
Last 12-Month Dividend iN/A$1.70
Last 12-Month Dividend Yield iN/A0.81%
3-Year Avg Annual Dividend iN/A$1.55
3-Year Avg Dividend Yield iN/A0.36%
3-Year Total Dividends iN/A$4.66
Ex-Dividend DateN/AApr 10, 2025